Contact this trialFirst, we need to learn more about you.
GLP-1R Agonist
Semaglutide for Type 2 Diabetes and Spinal Cord Injury
Recruiting2 awardsPhase 4
San Antonio, Texas
"This trial will investigate whether a new diabetes drug, semaglutide, is effective in treating type 2 diabetes in individuals with spinal cord injury. The study will focus on how semaglutide
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.